From ThoughtSpot 2019: National Diabetes Prevention Program

July 31, 2019 | Pamela Youngberg

The conceptual framework for a new diabetes prevention program went through a series of pilots across the country in 2016, each coming to the same conclusion: it works. Over the typical course of a 15-month program, healthcare cost savings of more than $2k per participant were achieved. The pilot programs, many of which were run through local YMCAs, provided enough proof of concept to warrant the launch of the National Diabetes Prevention Program which supplies education, coaching, and support to patients. Once those patient outcomes are met, with its built-in opportunity for profit, the program is a boon to pharmacists, who are often untapped resources in the fight against the disease.

In the “National Diabetes Prevention Program: An Opportunity for Pharmacy” presentation at ThoughtSpot 2019, co-presenters Bill Popomaronis (NCPA), Ashley Keller (STRAND Clinical Technologies), and Donna Avant, RPh (Ehrhardt Pharmacy), identified a few tips for taking advantage of the program in the community pharmacy setting.

Continue reading →

The Weekly Roundup: Continued State Action on Step Therapy (7.19.19)

July 19, 2019 | Pamela Youngberg

In May, CMS announced its final rule allowing step therapy for Medicare Part B drugs. Although various interests pushed back, the move had clearly been signaled, pushing legislators across the country into motion to counter—or at least clarify—the plans to mandate the approach. Almost two dozen states thus far have addressed step therapy—or as opponents like to refer to it, the “fail-first policy”—at their respective legislatures. This includes last year’s efforts in our home state of Minnesota and the bill signed this month in Wisconsin that seeks to provide for a more clear patient appeal process.

Continue reading →

Time to Buy or Sell? Keep it in the (independent) family.

July 12, 2019 | Pamela Youngberg

Owning a pharmacy is complicated. You are responsible for delivering the highest level of patient care. You are running a business in one of the most tumultuous and competitive markets the industry has ever seen. And, you are responsible for representing the voice of independent pharmacy both in your community and in your local, state, and national legislative bodies.

When it comes time to sell your pharmacy—or to add one to your existing roster of businesses—that complexity increases. But don’t worry if you haven’t mastered every aspect of the transition process. Here are a few things to keep in mind whether you are buying or selling:

Continue reading →

The Weekly Roundup: Alzheimer’s Awareness (7.5.19)

July 05, 2019 | Pamela Youngberg

Although Alzheimer’s Awareness Month has come to a close, there is still plenty of time to put together a team to join the Walk to End Alzheimer’s scheduled to take place near you. For Astrup Companies—the family-owned Minnesota company that started Smart-Fill; a couple of dozen retail, long-term care, and specialty pharmacies; and a smattering of other pharmacy-related businesses—supporting Alzheimer’s research is an important, and very personal, part of our mission. Our founder, Leonard Astrup, lost his battle with the disease five years ago, which is why we keep tabs on the latest research developments in the industry and companies that are emerging to make a difference in the fight to end the disease. It’s also what makes stories of thwarted research (login required) so disheartening. Many of our patients, and no doubt yours, have personal stories about how the disease has impacted their lives and the lives of those they love. To that end, we’re happy to share with our community some patient and caregiver resources as well as this downloadable sheet on the warning signs of disease, all of which you can feel free to share with your patients. For more information on how you can help, find your local Alzheimer’s Association chapter here.

Continue reading →

The Weekly Roundup: What's Next in Supply Chain Safety? (6.14.19)

June 14, 2019 | Pamela Youngberg

A pilot program announced this week seeks ways to use block chain technology to improve the prescription drug supply chain. “A permissioned block chain will provide an increased level of authority for patients and consumers, guaranteeing the drugs and vaccines they are receiving are not counterfeit, stolen, contaminated or harmful,” according to Craig Kennedy, senior vice president of supply chain at Merck, who is participating in the program with Walmart and technology partners IBM and KPMG. The new program is geared toward reducing the time associate with track-and-trace—a priority for the FDA based on its February program launch—and improving access and reliability. The potential for using the technology is vast, considering studies that have demonstrated that so much product is stolen, counterfeit, or damaged in transit. And while the so-called “porous” supply chain poses significant hazards to patients, it also adds significant cost to a system that has operated for decades in a black box.

Continue reading →

The Weekly Roundup: Next Steps for Step Therapy (5.31.19)

May 31, 2019 | Pamela Youngberg

On May 17, CMS announced its final rule on Medicare Part D and Medicare Advantage plans with a range of measures seeking greater transparency and negotiating power. The proposed rule had excited extensive comment from healthcare providers and patient advocacy groups on one aspect of the rule: that Medicare Advantage plans will allow the use of “utilization management tools, such as step therapy, for Part B drugs,” which CMS believes will enhance the ability of Medicare A plans to negotiate Part B drug costs. Not so fast, say many healthcare providers who want to put legislative guardrails around the practice of step therapy and thereby put “patients and doctors back in charge of healthcare.” Groups like the Arthritis Foundation were vocal supporters last month at the introduction by Reps. Raul Ruiz (D-CA) and Brad Wenstrup (R-OH)—both doctors—of H.R. 2279, The Safe Step Act. The federal legislation would require the establishment of a clear process for exceptions and impose time limits on insurer approval, and it mirrors many similar efforts at the state level. The National Psoriasis Foundation maintains a convenient map of activity in each state.

Continue reading →

The Weekly Roundup: Counseling for Travel Health (5.24.19)

May 24, 2019 | Pamela Youngberg

Repercussions from the U.S. measles outbreak continue to emerge. The latest victim: air travel, as officials leverage the CDC’s Do Not Board list as a deterrent against the spread of disease. As the summer travel season heats up, there is a range of considerations pharmacists can counsel patients on with the aim of increasing the likelihood of a healthy journey. In addition to proper vaccination, there is advice for avoiding insect-related illnesses and suggestions for an international first-aid kit. For certain patients, like your diabetes patients, there are specific recommendations. (There are special tips for those traveling by air here.)

Continue reading →

The Weekly Roundup: Skin Cancer Awareness (5.17.19)

May 17, 2019 | Pamela Youngberg

Skin cancer is on the rise, especially in Arizona, Colorado, and on the eastern seaboard. May is Skin Cancer Awareness Month, and it is a great time to increase conversations about sun protection—even in our Sterling pharmacies in Minnesota, where theoretically the last of the snow has come and gone (fingers crossed). Pharmacists have played a historic role in prevention and continue to do so today. These products are among those that your patients are reading about in the consumer press. Here are some tips for making sun protection recommendations in advance of Memorial Day Weekend. Consider sharing stories like this across your social feeds to raise awareness of the condition. Or, feel free to download or share this free resource to supplement your patient education.

Continue reading →